KYIV, Jan 6 – The growth of the pharmaceutical market will be 20% in 2021, the rates will be slightly lower in 2022, attention will be focused on chronic diseases, Ihor Nykyforchyn, Director of Medical Affairs at Pharmaceutical Firm Darnitsa, has said.

"The consolidated forecast for the pharmaceutical market growth is about 20% in 2021. In 2022, we expect a growth rate below previous year, but also in double digits. First of all, due to the increased attention to chronic diseases, which have taken a back seat now in connection with the pandemic, as well as due to the treatment of post-COVID conditions of those who have had COVID-19," he told Interfax-Ukraine.